Synairgen plc (SYGGF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
Jan 16, 2026, 9:30 AM EST
Synairgen Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
34
Market Cap
110.27K USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Scorpius Holdings | 2.41M |
| Endonovo Therapeutics | 255.72K |
| Eastgate Biotech | 137.64K |
| Affymax | 42.00K |
| CNBX Pharmaceuticals | 40.64K |
Synairgen News
- 1 year ago - AIM Market Roundup: Mkango, N4 Pharma, Minoan - The Armchair Trader
- 1 year ago - Small Cap Stocks: Borders & Southern, GENIP, Smarttech 247 - The Armchair Trader